A smartphone based AI model to detect left ventricular systolic dysfunction on 12-lead ECG

Abstract Background Despite echocardiography being essential for cardiac assessment, a point-of-care tool for rapid left ventricular ejection fraction (LVEF) evaluation is lacking in current clinical practice, highlighting the need for a widescale, easily deployable method to assess LV function. Purpose To develop and validate two artificial intelligence (AI) models that accurately detect reduced LVEF on a single 12-lead ECG using a smartphone, facilitating early identification of patients at risk for heart failure who may benefit from more detailed echocardiographic evaluation. Methods A large collection of ECGs and transthoracic echocardiograms (TTEs) was sourced from our hospital data vault from 2011 to 2021. ECGs were paired to TTEs within a 24h time window and the resulting pairs were randomly assigned to the model development dataset (50%) and validation dataset (50%). Two distinct AI-ECG models were developed: one to detect LVEF≤40% and another for LVEF<50%, derived from the ESC definition of heart failure. Both AI-ECG models were paired with smartphone based ECG digitization technology. Key performance metrics include area under the receiver operating characteristic curve (AUC), sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and F1-score. Results A total of 1,205,370 ECGs (198,274 patients) and 291,433 TTEs (105,849 patients) were collected and paired, resulting in 109,809 ECG-TTE pairs (56,236 patients). The validation dataset consisted of 25,510 distinct TTE-ECG pairs (25,510 patients). Prevalence of LVEF≤40% and LVEF<50% was 5.4% and 7.9% respectively. The LVEF≤40% model demonstrated an AUC of 0.963 (95% CI: 0.959-0.966), sensitivity 0.924 (95% CI: 0.91-0.937), specificity 0.887 (95% CI: 0.883-0.891), and F1-score of 0.474 (95% CI: 0.457-0.490). PPV and NPV were 0.318 (95% CI: 0.304-0.333) and 0.995 (95% CI: 0.994-0.996) respectively. Performance of the LVEF <50% model shows an AUC of 0.952 (95% CI: 0.947-0.956), with a slightly lower sensitivity of 0.899 (95% CI: 0.886-0.912), specificity of 0.875 (95% CI: 0.871-0.879), PPV of 0.382 (95% CI: 0.368-0.395), NPV of 0.99 (95% CI: 0.989-0.992), and F1-score of 0.536 (0.521-0.55). Conclusion The AI models exhibit the ability to identify reduced LVEF from standard 12-lead ECGs using a smartphone. Results suggest potential clinical utility as a preliminary screening tool to select patients for confirmatory echocardiography. This AI application could potentially offer a timely and cost-effective method for identifying patients at risk for future development of heart failure.

Authors

Institutions

Publication Details

Journal
European Heart Journal
Published
2024-10-01
DOI
https://doi.org/10.1093/eurheartj/ehae666.3477
Citations
1
Primary Topic
ECG Monitoring and Analysis
Type
article
Field-Weighted Citation Impact
0.40
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A smartphone based AI model to detect left ventricular systolic dysfunction on 12-lead ECG

Michael A. Herman, A Demolder, Ward Heggermont, Vladimír Boža et al.
1 citations
European Heart Journal
ECG Monitoring and Analysis
0.40
article

A smartphone based AI model to detect left ventricular systolic dysfunction on 12-lead ECG

Michael A. Herman, A Demolder, Ward Heggermont, Vladimír Boža, András Iring, Jozef Bartúnek, Timotej Palus, Róbert Hatala, Marc Vanderheyden, Robert Herman, Michal Martonak, Martin Pěnička, Jakub Bahyl, Boris Vavrik
article en
1 citations

Abstract

Abstract Background Despite echocardiography being essential for cardiac assessment, a point-of-care tool for rapid left ventricular ejection fraction (LVEF) evaluation is lacking in current clinical practice, highlighting the need for a widescale, easily deployable method to assess LV function. Purpose To develop and validate two artificial intelligence (AI) models that accurately detect reduced LVEF on a single 12-lead ECG using a smartphone, facilitating early identification of patients at risk for heart failure who may benefit from more detailed echocardiographic evaluation. Methods A large collection of ECGs and transthoracic echocardiograms (TTEs) was sourced from our hospital data vault from 2011 to 2021. ECGs were paired to TTEs within a 24h time window and the resulting pairs were randomly assigned to the model development dataset (50%) and validation dataset (50%). Two distinct AI-ECG models were developed: one to detect LVEF≤40% and another for LVEF<50%, derived from the ESC definition of heart failure. Both AI-ECG models were paired with smartphone based ECG digitization technology. Key performance metrics include area under the receiver operating characteristic curve (AUC), sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and F1-score. Results A total of 1,205,370 ECGs (198,274 patients) and 291,433 TTEs (105,849 patients) were collected and paired, resulting in 109,809 ECG-TTE pairs (56,236 patients). The validation dataset consisted of 25,510 distinct TTE-ECG pairs (25,510 patients). Prevalence of LVEF≤40% and LVEF<50% was 5.4% and 7.9% respectively. The LVEF≤40% model demonstrated an AUC of 0.963 (95% CI: 0.959-0.966), sensitivity 0.924 (95% CI: 0.91-0.937), specificity 0.887 (95% CI: 0.883-0.891), and F1-score of 0.474 (95% CI: 0.457-0.490). PPV and NPV were 0.318 (95% CI: 0.304-0.333) and 0.995 (95% CI: 0.994-0.996) respectively. Performance of the LVEF <50% model shows an AUC of 0.952 (95% CI: 0.947-0.956), with a slightly lower sensitivity of 0.899 (95% CI: 0.886-0.912), specificity of 0.875 (95% CI: 0.871-0.879), PPV of 0.382 (95% CI: 0.368-0.395), NPV of 0.99 (95% CI: 0.989-0.992), and F1-score of 0.536 (0.521-0.55). Conclusion The AI models exhibit the ability to identify reduced LVEF from standard 12-lead ECGs using a smartphone. Results suggest potential clinical utility as a preliminary screening tool to select patients for confirmatory echocardiography. This AI application could potentially offer a timely and cost-effective method for identifying patients at risk for future development of heart failure.

European Heart JournalVol. 45(Supplement_1)
Cardiovascular Research Center (BR), National Institute of Cardiovascular Diseases (PK)
Openalex Percentile: Top 31%
ECG Monitoring and Analysis
0.40
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.